UnknownNCT05975528
Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes
PHASE4 · 92 planned enrolment
- Countries listed
- 1
- Registry update
- May 9, 2024
immortal.lifeTrial registrations containing the exact intervention label glimepiride.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE4 · 92 planned enrolment
PHASE3 · 0 planned enrolment
PHASE3 · 1,091 planned enrolment